NM_015294.6(TRIM37):c.937del (p.Tyr313fs) AND Mulibrey nanism syndrome

Germline classification:: Likely pathogenic (1 submission)
Last evaluated:: Mar 27, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003474146.2

Allele description [Variation Report for NM_015294.6(TRIM37):c.937del (p.Tyr313fs)]

NM_015294.6(TRIM37):c.937del (p.Tyr313fs)

Gene:

TRIM37:tripartite motif containing 37 [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

17q22

Genomic location:

Preferred name:

NM_015294.6(TRIM37):c.937del (p.Tyr313fs)

HGVS:

NC_000017.11:g.59062574del
NG_009298.1:g.49334del
NG_009298.2:g.49308del
NM_001005207.5:c.937del
NM_001320987.3:c.835del
NM_001320988.3:c.937del
NM_001320989.3:c.937del
NM_001320990.3:c.571del
NM_001353082.2:c.835del
NM_001353083.2:c.202del
NM_001353084.2:c.937del
NM_001353085.2:c.475del
NM_001353086.2:c.886del
NM_015294.6:c.937delMANE SELECT
NP_001005207.1:p.Tyr313fs
NP_001307916.1:p.Tyr279fs
NP_001307917.1:p.Tyr313fs
NP_001307918.1:p.Tyr313fs
NP_001307919.1:p.Tyr191fs
NP_001340011.1:p.Tyr279fs
NP_001340012.1:p.Tyr68fs
NP_001340013.1:p.Tyr313fs
NP_001340014.1:p.Tyr159fs
NP_001340015.1:p.Tyr296fs
NP_056109.1:p.Tyr313fs
NC_000017.10:g.57139933del
NC_000017.10:g.57139935del
NR_148346.2:n.1356del
NR_148347.2:n.1254del

Protein change:

Y159fs

Molecular consequence:

NM_001005207.5:c.937del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001320987.3:c.835del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001320988.3:c.937del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001320989.3:c.937del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001320990.3:c.571del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001353082.2:c.835del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001353083.2:c.202del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001353084.2:c.937del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001353085.2:c.475del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001353086.2:c.886del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_015294.6:c.937del - frameshift variant - [Sequence Ontology: SO:0001589]
NR_148346.2:n.1356del - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148347.2:n.1254del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Mulibrey nanism syndrome
Synonyms:: Muscle-liver-brain-eye nanism; Pericardial constriction and growth failure; Perheentupa syndrome
Identifiers:: MONDO: MONDO:0009664; MedGen: C0524582; Orphanet: 2576; OMIM: 253250

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004204314	Baylor Genetics	criteria provided, single submitter (ACMG Guidelines, 2015)	Likely pathogenic (Mar 27, 2024)	unknown	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004204314

Baylor Genetics

criteria provided, single submitter

(ACMG Guidelines, 2015)

Likely pathogenic
(Mar 27, 2024)

unknown

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From Baylor Genetics, SCV004204314.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine